Medical technology investment expert Renee Ryan is recognized as an industry insider, a leading investor, a deal-maker, and a passionate innovator. She has over 25 years of experience building category-creating healthcare companies. Recently, Ryan served as CEO and Board member of Cala Health—a pioneer in wearable neuromodulation therapy, having launched two generations of products and consistently doubled revenue each year of her leadership. Before her work at Cala Health, she led the medical technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for eight years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Other investments include Auris Health, Verb Surgical, PowerVision, and Tusker Medical, all of which led to significant acquisitions. Previously, Ryan was a healthcare investment banker at Goldman Sachs and Jefferies Financial Group. She sits on the Boards of RefleXion Medical and Neuropace (NPCE).
Ryan earned an undergraduate degree in Economics from Georgetown University and an MBA from Columbia Business School.
Ryan earned an undergraduate degree in Economics from Georgetown University and an MBA from Columbia Business School.